Evidence map›Paper›PMID 36896197›Full record

ArticleInternational cancer conference journal2023

Rhabdomyosarcoma mimicking lymphoma.

Marziyeh Ghalamkari, Mahdi Khatuni, Haniyeh Radkhah, Saeed Farzanehfar, Behnaz Jahanbin

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in International cancer conference journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marziyeh GhalamkariHematology and Medical Oncology Department, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-7987-463X
Mahdi KhatuniInternal Medicine Department, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-5001-656X
Haniyeh RadkhahHematology and Medical Oncology Department , Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-7647-0787
Saeed FarzanehfarNuclear Medicine Department, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-5491-3492
Behnaz JahanbinPathology Department, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-2762-5591

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rhabdomyosarcoma (RMS) is a malignant soft tissue tumor that accounts for approximately one-half of soft tissue sarcomas in childhood age groups. Metastatic RMS is a rare condition that occurs in less than 25% of patients at diagnosis and can have variable clinical presentations. Case presentation: Here we report a 17-year-old boy with history of weight loss, fever and generalized bone pain admitted for severe hypercalcemia. The definite diagnosis of RMS was performed with immune-phenotyping of the metastatic lymph-node biopsy. The primary tumor site was not found. His bone scan showed diffuse bone metastasis and significant soft tissue technetium uptake due to extra-osseous calcification. Conclusion: Metastatic RMS can mimic lymphoproliferative disorders at presentation. Clinicians must be aware of this diagnosis especially in young adults.

Indexed as

Extra-osseous calcificationLymphoproliferative disorderMetastatic rhabdomyosarcoma

Identifiers

PMID36896197
PMCPMC9989065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.